Grants and Contracts Details
Description
Transfer Proposal -
Colorectal cancer is the second leading cause of cancer death in US. Most of colorectal cancers
are caused by APC mutation or beta-catenin mutation. We found that KLF4 interacts with betacatenin
and represses beta-catenin signaling and act as a tumor suppress.
Our central hypothesis is that KLF4 inhibits beta-catenin signaling in the differentiated cells;
conversely, beta-catenin inhibits KLF4 expression in proliferating cells, so KLF4lbeta-catenin
crosstalk defines the proliferating and differentiating compartment in the intestine. Up-regulation
of beta-catenin and down-regulation ofKLF4 together contributes to the initiation of colorectal
cancers.
We have three specific aims: 1) to delineate the mechanisms by which KLF4 inhibits betacatenin
signaling; 2) to determine the mechanisms ofAPC-regulated KLF4-expression in colon
cancer cells and APC-deleted intestine; and 3) to assess the functional effects ofKLF4lbetacatenin
crosstalk.
Status | Finished |
---|---|
Effective start/end date | 9/1/07 → 6/30/13 |
Funding
- National Institute Diabetes & Digestive & Kidney: $785,768.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.